TY - JOUR AU - Mateos, M. V. AU - San Miguel, J. F. PY - 2017 DA - 2017// TI - Management of multiple myeloma in the newly diagnosed patient JO - Hematology Am Soc Hematol Educ Program VL - 2017 UR - https://doi.org/10.1182/asheducation-2017.1.498 DO - 10.1182/asheducation-2017.1.498 ID - Mateos2017 ER - TY - JOUR AU - Fitzmaurice, C. AU - Akinyemiju, T. F. PY - 2018 DA - 2018// TI - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.2706 DO - 10.1001/jamaoncol.2018.2706 ID - Fitzmaurice2018 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Liu, W. AU - Liu, J. AU - Song, Y. PY - 2019 DA - 2019// TI - Mortality of lymphoma and myeloma in China, 2004-2017: an observational study JO - J Hematol Oncol VL - 12 UR - https://doi.org/10.1186/s13045-019-0706-9 DO - 10.1186/s13045-019-0706-9 ID - Liu2019 ER - TY - JOUR PY - 2017 DA - 2017// TI - Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)32152-9 DO - 10.1016/S0140-6736(17)32152-9 ID - ref5 ER - TY - JOUR PY - 2017 DA - 2017// TI - Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)32130-X DO - 10.1016/S0140-6736(17)32130-X ID - ref6 ER - TY - JOUR PY - 2017 DA - 2017// TI - Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)32154-2 DO - 10.1016/S0140-6736(17)32154-2 ID - ref7 ER - TY - JOUR AU - Sant, M. AU - Minicozzi, P. AU - Mounier, M. PY - 2014 DA - 2014// TI - Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70282-7 DO - 10.1016/S1470-2045(14)70282-7 ID - Sant2014 ER - TY - JOUR AU - Blimark, C. H. AU - Turesson, I. AU - Genell, A. PY - 2018 DA - 2018// TI - Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish myeloma registry JO - Haematologica. VL - 103 UR - https://doi.org/10.3324/haematol.2017.178103 DO - 10.3324/haematol.2017.178103 ID - Blimark2018 ER - TY - JOUR AU - Kristinsson, S. Y. AU - Landgren, O. AU - Dickman, P. W. PY - 2007 DA - 2007// TI - Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003 JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.0100 DO - 10.1200/JCO.2006.09.0100 ID - Kristinsson2007 ER - TY - JOUR AU - Kim, K. AU - Lee, J. H. AU - Kim, J. S. PY - 2014 DA - 2014// TI - Clinical profiles of multiple myeloma in Asia-an Asian myeloma network study JO - Am J Hematol VL - 89 UR - https://doi.org/10.1002/ajh.23731 DO - 10.1002/ajh.23731 ID - Kim2014 ER - TY - JOUR AU - Lu, J. AU - Lu, J. AU - Chen, W. PY - 2014 DA - 2014// TI - Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis JO - Blood Cancer J VL - 4 UR - https://doi.org/10.1038/bcj.2014.55 DO - 10.1038/bcj.2014.55 ID - Lu2014 ER - TY - JOUR AU - Cowan, A. J. AU - Allen, C. AU - Barac, A. AU - Basaleem, H. AU - Bensenor, I. AU - Curado, M. P. PY - 2018 DA - 2018// TI - Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016 JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.2128 DO - 10.1001/jamaoncol.2018.2128 ID - Cowan2018 ER - TY - JOUR AU - Curado, M. P. AU - Oliveira, M. M. AU - Silva, D. R. M. PY - 2018 DA - 2018// TI - Epidemiology of multiple myeloma in 17 Latin American countries: an update JO - Cancer Med VL - 7 UR - https://doi.org/10.1002/cam4.1347 DO - 10.1002/cam4.1347 ID - Curado2018 ER - TY - JOUR AU - Vélez, R. AU - Turesson, I. AU - Landgren, O. PY - 2016 DA - 2016// TI - Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2015-009584 DO - 10.1136/bmjopen-2015-009584 ID - Vélez2016 ER - TY - JOUR AU - Sun, T. AU - Wang, S. AU - Sun, H. PY - 2018 DA - 2018// TI - Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades JO - Leuk Lymphoma VL - 59 UR - https://doi.org/10.1080/10428194.2017.1335398 DO - 10.1080/10428194.2017.1335398 ID - Sun2018 ER - TY - JOUR AU - Sung, H. AU - Siegel, R. L. AU - Torre, L. A. PY - 2019 DA - 2019// TI - Global patterns in excess body weight and the associated cancer burden JO - CA Cancer J Clin VL - 69 ID - Sung2019 ER - TY - JOUR AU - Kumar, S. K. AU - Rajkumar, V. AU - Kyle, R. A. PY - 2017 DA - 2017// TI - Multiple myeloma JO - Nat Rev Dis Primers VL - 3 UR - https://doi.org/10.1038/nrdp.2017.46 DO - 10.1038/nrdp.2017.46 ID - Kumar2017 ER - TY - JOUR PY - 2017 DA - 2017// TI - Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)32366-8 DO - 10.1016/S0140-6736(17)32366-8 ID - ref19 ER -